Gene: ZSCAN18
Official Full Name: zinc finger and SCAN domain containing 18provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11884 | ZSCAN18 Knockout cell line (HEK293) | Human | ZSCAN18 | 1:3~1:6 | Negative | Online Inquiry |
KO11885 | ZSCAN18 Knockout cell line (A549) | Human | ZSCAN18 | 1:3~1:4 | Negative | Online Inquiry |
ZSCAN18 Gene Knockout Cell Lines represent a cutting-edge biological tool specifically designed for the functional analysis of the ZSCAN18 gene, which is implicated in various cellular processes including gene regulation and response to stress. These genetically engineered cell lines are crafted using CRISPR/Cas9 technology, ensuring a high degree of precision in creating knockout models that enable researchers to elucidate the gene's role in specific biological pathways.
The primary function of ZSCAN18 Gene Knockout Cell Lines is to facilitate the exploration of the gene's effects on cellular physiology, gene expression, and regulatory mechanisms. By removing the ZSCAN18 gene's expression, researchers can investigate downstream consequences and identify potential compensatory pathways that are activated in response to its loss. This knockout model is invaluable for dissecting the molecular processes underlying disease states and for potentially illuminating novel therapeutic targets.
In the realm of scientific research and clinical applications, these cell lines are particularly significant for studies in oncology, developmental biology, and genetics. They provide a vital platform for drug screening, gene therapy research, and understanding the mechanisms of gene-related diseases. The ability to observe the direct impacts of ZSCAN18 absence on cell behavior and function opens avenues for targeted therapies and elucidates the complexities of gene interactions in health and disease.
What sets ZSCAN18 Gene Knockout Cell Lines apart from alternatives is their enhanced specificity and reliability, owing to the rigorous validation processes our company employs. Unlike other knockout models, these lines are characterized by consistent performance in diverse experimental setups, enabling researchers to achieve reproducible and robust results. Additionally, our product comes with user-friendly protocols and expert support, ensuring seamless integration into existing workflows.
For researchers and clinicians focused on advancing our understanding of specific gene functions or developing novel therapeutic approaches, ZSCAN18 Gene Knockout Cell Lines present an indispensable resource. The ability to manipulate gene expression with unparalleled accuracy empowers scientists to drive innovations in biomedical knowledge and healthcare solutions.
At [Company Name], we pride ourselves on our extensive expertise in genetic engineering and developmental biology, coupled with a commitment to delivering high-quality products that address current challenges in research and clinical settings. Our dedication to scientific excellence ensures that our offerings, including ZSCAN18 Gene Knockout Cell Lines, contribute meaningful advancements in the field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.